Comparison of Mutational Status in the EGFR Pathway Across Four Different Platforms in the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial

Westwood, AC, Bottomley, D, Hemmings, GJ et al. (11 more authors) (2018) Comparison of Mutational Status in the EGFR Pathway Across Four Different Platforms in the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial. In: Journal of Pathology. Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht. Wiley , S15-S15.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. This is the author accepted version of an oral abstract presented at the Maastricht Pathology 2018 Conference. The final version has been published in the Journal of Pathology at: https://doi.org/10.1002/path.5165
Dates:
  • Accepted: 20 April 2018
  • Published (online): 6 September 2018
  • Published: 6 September 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Funding Information:
FunderGrant number
Cancer Research UKRCS REF 08-0843 SUBCONTR
Yorkshire Cancer ResearchL354 PA
Yorkshire Cancer ResearchL386
Depositing User: Symplectic Publications
Date Deposited: 11 Dec 2018 14:23
Last Modified: 06 Sep 2019 00:39
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/path.5165
Related URLs:

Share / Export

Statistics